RSS

biomarkers

Diagnostics company, Owlstone Medical, has signed a service agreement with global biopharmaceutical company, AstraZeneca, to explore how breath can be used to identify novel biomarkers for personalised medicine applications. Read more

News

Q BioMed, a biomedical acceleration and development company, has signed an exclusive option agreement with Washington University in St Louis for a novel companion biomarker for monitoring glaucoma. Read more

News

A new promising biomarker for colorectal cancer (CRC) that might benefit therapy and patient survival rates has been found by researchers from the University of Luxembourg. Read more

News

A study from researchers at Yale School of Medicine, evaluating cardiovascular trials with primary surrogate endpoints from the past 20 years, have found a disconnect between these trials and clinical outcomes. Read more

News

BBI Solutions have launched more than 20 new antibodies in their product portfolio as a result of demands in the market place. This extended portfolio now includes cardiac, cancer, inflammation and fertility markers. Read more

News

Diagnostics company, Owlstone Medical, who is developing a breathalyser for disease has announced it has signed a master service agreement with pharmaceutical company 4D Pharma. Read more

News

One of Europe’s largest collaborative academic-industry research projects, designed to develop and assess novel approaches for identification of new markers for colon cancer, has been conducted by public-private consortium OncoTrack. Read more

News

Biocartis has signed a collaboration agreement with Merck for the development and commercialisation of a new liquid biopsy RAS biomarker test for patients with metastatic colorectal cancer (mCRC) Read more

News

Dr Alexandre Akoulitchev, Oxford BioDynamics, talks to EPM about biomarkers aiding diagnostics and new treatments Read more

Opinion

SGS Life Science Services, a clinical and bioanalytical contract group has invested in additional modules for its COBAS 6000 analysis system, to increase its biomarker analytical capabilities. Read more

News

Harlan Contract Research Services and Bertin Pharma have announced a strategic partnership to offer a comprehensive package for early drug development. Under the agreement, the companies will offer a wider range of drug discovery and translational... Read more

Technology

LGC and Quotient Bioresearch are pleased to announce that they have reached agreement on the sale by Quotient of its Bioanalytical Sciences division to LGC. Read more

Technology